Seres Therapeutics MCRB
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 19.24 | -273.98 | 1.96 | 0.93 | -22,477 | 8 |
| 2025Q2 | 11.11 | 125.31 | 1.33 | -2.28 | -24,881 | -20 |
| 2025Q1 | 14.00 | -83.34 | 897.56 | 3.75 | -27,236 | 33 |
| 2024Q4 | 16.62 | 184.40 | 1043.26 | -2.10 | -28,835 | -16 |
| 2024Q3 | 18.92 | 57.16 | 11.91 | -29,171 | 89 | |
| 2024Q2 | 14.48 | 111.91 | -4.32 | -36,493 | -33 | |
| 2024Q1 | 15.48 | 111.60 | -5.49 | -39,586 | -40 | |
| 2023Q4 | 28.00 | 95.60 | -6.40 | 50,090 | -41 | |
| 2023Q3 | 47.60 | 108.15 | -0.38 | -47,413 | -48 | |
| 2023Q2 | 95.80 | 99.57 | 7.60 | 49,524 | 47 | |
| 2023Q1 | 113.40 | -11.40 | -70,568 | -71 | ||
| 2022Q4 | 112.00 | 102.08 | -0.54 | -68,307 | -69 | |
| 2022Q3 | 128.40 | 101.43 | -9.00 | -59,107 | -60 | |
| 2022Q2 | 68.60 | 100.14 | -14.20 | -63,325 | -65 | |
| 2022Q1 | 142.40 | 100.07 | -12.20 | -55,751 | -57 | |
| 2021Q4 | 166.60 | 100.34 | -11.00 | -49,432 | -50 | |
| 2021Q3 | 139.20 | 99.20 | 14.80 | 68,407 | 68 | |
| 2021Q2 | 477.00 | 101.14 | -10.40 | -48,142 | -48 | |
| 2021Q1 | 411.80 | 101.60 | -7.80 | -35,326 | -35 | |
| 2020Q4 | 490.00 | 102.32 | -3.80 | -17,898 | -18 |